Contradictory with the previous reports, our results indicated that S100A8/A9 was significantly up-regulated in both serum and tissue of ESCC patients compared with controls and exhibited high sensitivity and specificity for distinguishing ESCC patients from controls with an AUC of 0.887. Here, S100A8 is linked to esophageal squamous cell carcinoma.